Blinded Outcome Assessment Was Infrequently Used and Poorly Reported in Open Trials.

by Brennan C Kahan, Sunita Rehal, Suzie Cro
Published 2015-01-01

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis

by Gregory Klein, Paul Delmar, Nicola Voyle, Sunita Rehal, Carsten Hofmann, Danielle Abi-Saab, Mirjana Andjelkovic, Smiljana Ristic, Guoqiao Wang, Randall Bateman, Geoffrey A. Kerchner, Monika Baudler, Paulo Fontoura, Rachelle Doody
Published 2019-12-01